Sonoma Pharmaceuticals, Inc. (SNOA) stock
Close on Nov 17, 2026Market cap $3.99MP/E –Yield –
Earnings
Sonoma Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Sonoma Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2019ended Sep 30, 2018 | Nov 8, 2018after the close | – | – | – | Filing |
| Q1 FY2019ended Jun 30, 2018 | Aug 8, 2018after the close | – | – | – | Filing |
| Q4 FY2018ended Mar 31, 2018 | Jun 13, 2018after the close | – | – | – | Filing |
| Q3 FY2018ended Dec 31, 2017 | Feb 7, 2018after the close | – | – | – | Filing |
| Q2 FY2018ended Sep 30, 2017 | Nov 9, 2017after the close | – | – | – | Filing |
| Q1 FY2018ended Jun 30, 2017 | Aug 8, 2017after the close | – | – | – | Filing |
| Q4 FY2017ended Mar 31, 2017 | Jun 5, 2017after the close | – | – | – | Filing |
| Q3 FY2017ended Dec 31, 2016 | Feb 9, 2017after the close | – | – | – | Filing |
| Q2 FY2017ended Sep 30, 2016 | Nov 10, 2016after the close | – | – | – | Filing |
| Q1 FY2017ended Jun 30, 2016 | Jul 28, 2016after the close | – | – | – | Filing |
| Q4 FY2016ended Mar 31, 2016 | Jun 16, 2016after the close | – | – | – | Filing |
| Q3 FY2016ended Dec 31, 2015 | Feb 4, 2016after the close | – | – | – | Filing |
| Q2 FY2016ended Sep 30, 2015 | Nov 5, 2015after the close | – | – | – | Filing |
| Q1 FY2016ended Jun 30, 2015 | Jul 30, 2015after the close | – | – | – | Filing |
| Q4 FY2015ended Mar 31, 2015 | Jun 11, 2015after the close | – | – | – | Filing |
| Q2 FY2015ended Sep 30, 2014 | Nov 13, 2014after the close | – | – | – | Filing |
| Q1 FY2015ended Jun 30, 2014 | Aug 7, 2014after the close | – | – | – | Filing |
| Q4 FY2014ended Mar 31, 2014 | Jun 12, 2014after the close | – | – | – | Filing |
| Q3 FY2014ended Dec 31, 2013 | Feb 13, 2014after the close | – | – | – | Filing |
| Q2 FY2014ended Sep 30, 2013 | Nov 19, 2013after the close | – | – | – | Filing |
| Q1 FY2014ended Jun 30, 2013 | Aug 8, 2013after the close | – | – | – | Filing |
| Q4 FY2013ended Mar 31, 2013 | Jun 13, 2013after the close | – | – | – | Filing |
| Q3 FY2013ended Dec 31, 2012 | Feb 13, 2013after the close | – | – | – | Filing |
| Q2 FY2013ended Sep 30, 2012 | Nov 1, 2012after the close | – | – | – | Filing |
| Q1 FY2013ended Jun 30, 2012 | Aug 2, 2012after the close | – | – | – | Filing |
| Q4 FY2012ended Mar 31, 2012 | Jun 7, 2012after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Sonoma Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Sonoma Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Sonoma Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
- Update
- Update
- Update
- Update
- News
- Update
- Update
- Update
- Update
See a number that looks wrong?